Overview
A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Prednisone was granted FDA approval on 21 February 1955.
Background
A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Prednisone was granted FDA approval on 21 February 1955.
Indication
Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
Associated Conditions
- Acne Vulgaris
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Acute Gouty Arthritis
- Acute Leukemia
- Aggressive Lymphoma
- Allergic Bronchopulmonary Aspergillosis
- Allergic Conjunctivitis (AC)
- Allergic Rhinitis (AR)
- Allergic corneal marginal ulcers
- Alveolitis, Extrinsic Allergic
- Ankylosing Spondylitis (AS)
- Aspiration Pneumonitis
- Asthma
- Atopic Dermatitis
- Autoimmune Hepatitis
- Bell's Palsy
- Berylliosis
- Bullous dermatitis herpetiformis
- Chorioretinitis
- Congenital Adrenal Hyperplasia (CAH)
- Congenital Hypoplastic Anemia
- Contact Dermatitis
- Disseminated tuberculosis
- Drug hypersensitivity reaction
- Edema of the cerebrum
- Epicondylitis
- Erythroblastopenia
- Giant Cell Arteritis (GCA)
- Hypercalcemia of Malignancy
- Idiopathic Pulmonary Fibrosis (IPF)
- Immune Thrombocytopenia (ITP)
- Iridocyclitis
- Iritis
- Keratitis
- Leukemias
- Loeffler's syndrome
- Lymphoma
- Meningitis caused by Mycobacterium Tuberculosis
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Mycosis Fungoides (MF)
- Ocular Inflammation
- Ophthalmia, Sympathetic
- Optic Neuritis
- Pain caused by Herpes zoster
- Pemphigus
- Pericarditis
- Pneumocystis Jirovecii Pneumonia
- Polymyalgia Rheumatica (PMR)
- Polymyositis
- Posterior Uveitis
- Primary adrenocortical insufficiency
- Psoriatic Arthritis
- Pure Red Cell Aplasia
- Regional Enteritis
- Relapsing Polychondritis
- Rheumatoid Arthritis
- Rheumatoid Arthritis, Juvenile
- Secondary adrenocortical insufficiency
- Secondary thrombocytopenia
- Serum Sickness
- Severe Seborrheic Dermatitis
- Sjogren's Syndrome (SS)
- Solid Organ Transplant Rejection
- Stevens-Johnson Syndrome
- Systemic Lupus Erythematosus
- Takayasu Arteritis
- Thyroid Eye Disease
- Thyroiditis
- Thyrotoxicosis
- Trichinosis
- Ulcerative Colitis
- Uveitis
- Vasculitis
- Acquired immune hemolytic anemia
- Acute Bursitis
- Acute Crohn's Disease (CD)
- Acute Multiple sclerosis exacerbation
- Acute rheumatic carditis
- Anterior eye segment inflammation
- Exfoliative erythroderma
- Fulminating Tuberculosis
- Idiopathic Bronchiolitis obliterans with organizing pneumonia
- Idiopathic eosinophilic pneumonias
- Non-suppurative Thyroiditis
- Severe Psoriasis
- Subacute Bursitis
- Symptomatic Sarcoidosis
- Synovitis of osteoarthritis
- Systemic Dermatomyositis
- Varicella-zoster virus acute retinal necrosis
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2009/10/02 | Phase 3 | Completed | |||
2009/09/30 | Phase 4 | Completed | |||
2009/09/24 | Phase 2 | Withdrawn | |||
2009/09/11 | Phase 4 | Completed | University Hospital, Basel, Switzerland | ||
2009/09/09 | Phase 3 | Completed | University Hospital, Basel, Switzerland | ||
2009/09/09 | Phase 2 | Completed | |||
2009/09/07 | Phase 1 | Active, not recruiting | |||
2009/09/07 | Phase 2 | UNKNOWN | |||
2009/08/11 | Not Applicable | UNKNOWN | Health Science Center of Xi'an Jiaotong University | ||
2009/07/24 | Phase 2 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||